Asset Manager

Updated:

LYVA Labs

LYVA Labs went live in 2021 with £10.5 million from the Liverpool City Region Combined Authority, making it one of the UK's few public-sector-anchored...

LYVA Labs logo

LYVA Labs

LYVA Labs went live in 2021 with £10.5 million from the Liverpool City Region Combined Authority, making it one of the UK's few public-sector-anchored innovation investors with a pure equity mandate. The firm operates as a registered asset manager rather than a grant body, targeting Seed to Series A opportunities from the region's universities, NHS trusts, and science parks. Their founding logic was structural: Liverpool's research outputs were leaving town for Manchester, London, and the southeast. LYVA Labs was built as the local capture mechanism — infrastructure that would keep discoveries, and the companies they become, inside the city region. The investment strategy spans life sciences, advanced manufacturing, and digital. Confirmed partners include the Infection Innovation Consortium (iiCON), a global center for infection R&D; the Science and Technology Facilities Council; and Sci-Tech Daresbury, a national lab campus. The firm runs its own accelerator programs and an Advanced Manufacturing Innovation Network with over 600 members, using both pipelines to source deal flow. Portfolio activity spans spin-outs from the University of Liverpool and co-investments alongside Innovate UK grants. The model is fund-of-funds adjacent: LYVA Labs syndicates with national agencies and corporate R&D arms rather than competing for sole-led Series A terms. LYVA Labs also administers thematic challenge funds, including a Clean Tech for Health Challenge Fund and an R&D Partnership Fund, blurring the line between public grant administrator and commercial investor. The Spine, a commercial office building in Liverpool's Paddington Village science district, sits in their asset portfolio through Scitontec AI. In May 2024, the firm formalized its national footprint by deepening ties with Innovate UK under a joint regional accelerator framework (per the firm's official communications, 2024). The structural differentiator is the hybrid public-private design. No other UK regional innovation body operates a direct equity mandate alongside challenge fund administration and a commercial real estate portfolio under one entity. The next test is whether the investment committee — whose composition is not publicly disclosed — can maintain commercial discipline through the political cycles of the Combined Authority that seeded it.

General information

Firm type

Generalist

Year founded

2021

Location

Region

Europe

Country

United Kingdom

City

Liverpool

Corporate office

Liverpool, United Kingdom

Sector focus

Life SciencesAdvanced ManufacturingAI/MLDigital HealthClimateTechEnterprise Software

Frequently asked questions

Who provides the capital LYVA Labs deploys?

The Liverpool City Region Combined Authority seeded LYVA Labs with £10.5 million in 2021. The firm does not publicly disclose whether subsequent funding rounds or co-investment vehicles have added to that base, though partnership structures with Innovate UK and STFC suggest grant-linked follow-on capital flows through specific projects rather than into a single pooled fund.

How does LYVA Labs source deal flow differently from a typical regional venture firm?

LYVA Labs operates an Advanced Manufacturing Innovation Network of over 600 members and sits as a core consortium partner for iiCON, the infection R&D hub. These are not passive networks — the firm runs accelerator programs inside them and uses formal MoUs with the University of Liverpool and Sci-Tech Daresbury to access spin-outs and licensing opportunities before they reach open venture rounds.

Does LYVA Labs operate as a single fund, a holding company, or a program vehicle?

It is structured as an asset manager rather than a closed-end fund. LYVA Labs holds direct equity stakes in portfolio companies, manages innovation ecosystem properties including The Spine office building, and administers ring-fenced challenge funds like the Clean Tech for Health Challenge Fund. This is a balance-sheet-plus-programs model, not a traditional LP/GP fund.

What investment stages does LYVA Labs typically target?

LYVA Labs concentrates on pre-seed through Series A, with heavy emphasis on university spin-outs and grant-gated technologies that need technical de-risking before institutional venture money arrives. Their partnership with Innovate UK suggests many portfolio companies arrive with at least one non-dilutive grant already secured.

Which sectors does LYVA Labs explicitly avoid?

The firm has not published an exclusion list. However, its active partnerships — iiCON for infection R&D, STFC for physics-based technologies, the Advanced Manufacturing network — and its Clean Tech for Health thematic fund signal concentration in deep tech, life sciences, and industrial innovation. Consumer internet, retail, and pure SaaS without a hardware or science layer appear absent from disclosed activity.

Who runs investment decisions at LYVA Labs?

LYVA Labs has not publicly disclosed the names of its investment committee members or managing partners. The organization's governance relationship with the Liverpool City Region Combined Authority — its founding funder — is central to its structure but the specific decision-making process and separation between political oversight and investment decisions are not publicly documented.

Is LYVA Labs a single-family office, a venture firm, or something else?

It is a publicly seeded asset manager with a civic innovation mandate — neither a family office nor a traditional for-profit venture firm. The Combined Authority provided the original capital, but LYVA Labs makes commercial equity investments, collects returns, and manages physical property. The model echoes a sovereign wealth fund at regional scale, though with lighter reporting requirements than a central government entity.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Liverpool Generalist profiles